Shenzhen Chipscreen Biosciences Co (688321) — Financial Flexibility Index
Shenzhen Chipscreen Biosciences Co (688321) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥63.98 Million (operating CF CN¥2.25 Million minus capex CN¥61.73 Million) represents 0% of total liabilities (CN¥1.98 Billion). Check 688321 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shenzhen Chipscreen Biosciences Co Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Shenzhen Chipscreen Biosciences Co across 9 annual periods. For the full cash flow conversion analysis, see 688321 cash flow conversion.
Annual Financial Flexibility Index for Shenzhen Chipscreen Biosciences Co (2016–2024)
Year-by-year free cash flow to debt coverage for Shenzhen Chipscreen Biosciences Co. Explore 688321 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.21x | CN¥344.62 Million | CN¥76.13 Million | CN¥1.67 Billion | ▲ +259.1% |
| 2023 | 0.06x | CN¥85.82 Million | CN¥-143.21 Million | CN¥1.49 Billion | ▼ -82.9% |
| 2022 | 0.34x | CN¥443.46 Million | CN¥43.30 Million | CN¥1.32 Billion | ▼ -61.2% |
| 2021 | 0.87x | CN¥413.25 Million | CN¥124.78 Million | CN¥476.79 Million | ▼ -53.1% |
| 2020 | 1.85x | CN¥429.89 Million | CN¥93.62 Million | CN¥232.44 Million | ▲ +317.9% |
| 2019 | 0.44x | CN¥108.47 Million | CN¥-24.55 Million | CN¥245.10 Million | ▼ -35.2% |
| 2018 | 0.68x | CN¥163.52 Million | CN¥22.78 Million | CN¥239.44 Million | ▲ +3.5% |
| 2017 | 0.66x | CN¥135.56 Million | CN¥2.73 Million | CN¥205.47 Million | ▼ -0.3% |
| 2016 | 0.66x | CN¥125.58 Million | CN¥59.77 Million | CN¥189.73 Million | — |